NCT03416543 Effect of a New BI-specifiC Antibody Towards Dendritic Cells on Inflammation in Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT03388515 A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects. Status UNKNOWN Phase PHASE1
NCT03345186 A Nurse Led Patient Management Programme to Improve Outcomes in Gout Status COMPLETED Phase NA
NCT03336203 The Impact of Urate-lowering Therapy on Kidney Function (IMPULsKF) Status UNKNOWN Phase PHASE4
NCT03306758 The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout Status UNKNOWN Phase NA
NCT03291782 D-0120 Safety and PK/PD, Food Effect Study in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT03272425 Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence. Status COMPLETED Phase PHASE1
NCT03226899 A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment Status TERMINATED Phase PHASE4
NCT03214263 Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases Status RECRUITING Phase N/A
NCT03211403 Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level Status COMPLETED Phase PHASE1
NCT03162341 Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit Status COMPLETED Phase NA
NCT03131583 The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout Status COMPLETED Phase PHASE1
NCT03038386 Diagnostic Value of DECT Scan Compared to Diagnostic Needle Aspiration Status UNKNOWN Phase NA
NCT02903446 Denosumab In Addition To Intense Urate-Lowering Therapy for Bone Erosions Status COMPLETED Phase PHASE2
NCT02741700 SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO2 Study Status COMPLETED Phase NA